{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:13:48Z","timestamp":1782285228813,"version":"3.54.5"},"reference-count":77,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World j. surg."],"published-print":{"date-parts":[[1986,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Cyclosporin (CsA) therapy has improved the outcome of allotransplants. Because of a relatively selective action on T lymphocytes, CsA therapy causes fewer immunosuppressive complications of infection or malignancy compared to previous chemical agents, which were relatively nonspecific in their spectrum of action on lymphoid versus nonlymphoid cells. Gastrointestinal complaints after oral administration and vasomotor reactions after intravenous administration represent pharmacologic toxicities rarely of major clinical import. Drug\u2010induced complications involve primarily the neuroectodermal, or the mesenchymal hepatic and renal, systems. While the former group of complications are rarely severe, mesenchymal nephrotoxicity poses a major limitation of drug therapy. On the one hand, reductions by 33% of normal renal function in patients treated with CsA for autoimmune disease appear to be reversible on discontinuance of therapy. On the other hand, severe renal dysfunction occurs in transplant recipients, particularly in the presence of concomitant therapy with nephrotoxic drugs. In the kidney transplant setting, numerous factors exacerbate the druginduced injury, including adverse donor procurement conditions, prolonged graft storage, and allograft rejection. Since the clinical and histologic findings in CsA nephrotoxicity tend to be pleiomorphic, no single diagnostic or therapeutic strategy has emerged. However, insights gained through pharmacologic monitoring of renal allograft recipients suggest that the group at increased risk for nephrotoxicity can be identified by elevated serum drug trough levels, increased area under the plasma time concentration curve, prolonged elimination half\u2010life, and heightened pharmacodynamic sensitivity to CsA. Analysis of pharmacologic data in conjunction with clinical results should provide drug regimens of maximal therapeutic index with minimal risk of complications<\/jats:bold>.<\/jats:p>","DOI":"10.1007\/bf01655294","type":"journal-article","created":{"date-parts":[[2005,5,8]],"date-time":"2005-05-08T02:57:32Z","timestamp":1115521052000},"page":"348-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Complications of cyclosporin therapy"],"prefix":"10.1002","volume":"10","author":[{"given":"Barry D.","family":"Kahan","sequence":"first","affiliation":[{"name":"Division of Immunology and Organ Transplantation Department of Surgery The University of Texas Medical School at Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Flechner","sequence":"additional","affiliation":[{"name":"Division of Immunology and Organ Transplantation Department of Surgery The University of Texas Medical School at Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc I.","family":"Lorber","sequence":"additional","affiliation":[{"name":"Division of Immunology and Organ Transplantation Department of Surgery The University of Texas Medical School at Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jensen","sequence":"additional","affiliation":[{"name":"Division of Immunology and Organ Transplantation Department of Surgery The University of Texas Medical School at Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Golden","sequence":"additional","affiliation":[{"name":"Division of Immunology and Organ Transplantation Department of Surgery The University of Texas Medical School at Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Van Buren","sequence":"additional","affiliation":[{"name":"Division of Immunology and Organ Transplantation Department of Surgery The University of Texas Medical School at Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1986,6]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92440-1"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198310063091401"},{"key":"e_1_2_1_4_1","first-page":"2917","article-title":"The effects of cyclosporine on viruses","volume":"15","author":"Ho M.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_5_1","unstructured":"Jarowenko M. Pifer L. Kerman R. Kahan B.D.:Serologic methods for the early diagnosis of Pneumocystis carinii infection in renal allograft recipients. Transplantation (in press)."},{"key":"e_1_2_1_6_1","first-page":"2798","article-title":"Immunoglobulin abnormalities and infectious lymphoproliferative syndrome (ILPS) in cyclosporine\u2010treated transplant patients","volume":"15","author":"Touraine J.L.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90994-2"},{"key":"e_1_2_1_8_1","first-page":"2790","article-title":"Lymphomas complicating organ transplantation","volume":"15","author":"Penn I.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90604-3"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90219-8"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198505093121916"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92171-3"},{"key":"e_1_2_1_13_1","first-page":"636","article-title":"Anaphylactic reaction to intravenous cyclosporin","volume":"1","author":"Ptachcinski R.J.","year":"1985","journal-title":"Lancet"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198410000-00005"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91793-2"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.131.2.712"},{"key":"e_1_2_1_17_1","first-page":"446","article-title":"Pharmacokinetics of cyclosporine in human renal transplantation","volume":"15","author":"Kahan B.D.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198112000-00007"},{"key":"e_1_2_1_19_1","first-page":"1195","article-title":"The value of serial serum trough cyclosporine levels in human renal transplantation","volume":"16","author":"Kahan B.D.","year":"1984","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_20_1","first-page":"125","article-title":"Clinical and experimental studies using cyclosporine in renal transplantation","volume":"97","author":"Kahan B.D.","year":"1985","journal-title":"Surgery"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(85)80161-X"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198310000-00019"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00302721"},{"key":"e_1_2_1_24_1","first-page":"422","article-title":"Hepatic glutathione reduction associated with the use of cyclosporin A","volume":"9","author":"Perura J.","year":"1982","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"e_1_2_1_25_1","first-page":"54","article-title":"De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine","volume":"98","author":"Van Buren D.","year":"1985","journal-title":"Surgery"},{"key":"e_1_2_1_26_1","first-page":"202","article-title":"The effect of cyclosporine on renal function in newly diagnosed diabetics","volume":"17","author":"Stiller C.R.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_27_1","first-page":"209","article-title":"Cyclosporine\u2010induced nephrotoxicity in patients with autoimmune uveitis","volume":"17","author":"Palestine A.G.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_28_1","first-page":"215","article-title":"Renal function in patients with autoimmune diseases treated with cyclosporine","volume":"17","author":"von Graffenried B.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1985.00360030153026"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(85)80159-1"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198309000-00008"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91851-1"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90173-3"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198309000-00025"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198207000-00007"},{"key":"e_1_2_1_36_1","first-page":"196","article-title":"Cyclosporine\u2010associated renal dysfunction in marrow transplant recipients","volume":"17","author":"Yee G.C.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_37_1","first-page":"101","article-title":"Morphological patterns in cyclosporine\u2010treated renal transplant recipients","volume":"17","author":"Mihatsch M.J.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198209000-00012"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(85)80157-8"},{"key":"e_1_2_1_40_1","first-page":"282","article-title":"Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine\u2010induced nephrotoxicity in renal transplant recipients","volume":"17","author":"Lorber M.I.","year":"1985","journal-title":"Transplant Proc."},{"key":"e_1_2_1_41_1","first-page":"88","article-title":"Experimental cyclosporin A nephrotoxicity","volume":"63","author":"Whiting P.H.","year":"1982","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_2_1_42_1","first-page":"51","article-title":"Pathogenic mechanisms of nephrotoxicity: Insights into cyclosporine nephrotoxicity","volume":"17","author":"Humes H.D.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_43_1","first-page":"81","article-title":"Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity","volume":"17","author":"Weinberg J.M.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_44_1","first-page":"123","article-title":"Reflections on use of the renal biopsy as the \u201cgold standard\u201d in distinguishing transplant rejection from cyclosporine nephrotoxicity","volume":"17","author":"Solez K.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_45_1","unstructured":"Kahan B.D. Kramer W.G. Wideman C. Flechner S.M. Lorber M.I. Van Buren C.T.:Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplantation (in press)."},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(85)90192-3"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198301000-00018"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198303000-00005"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90321-4"},{"key":"e_1_2_1_50_1","first-page":"693","article-title":"Renal and hepatic function in rats treated with cyclosporin A in combination with gentamicin or cephalosporin antibiotics","volume":"64","author":"Whiting P.H.","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91544-6"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198308000-00021"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92352-3"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198409133111103"},{"key":"e_1_2_1_55_1","first-page":"185","article-title":"Cyclosporine\u2010induced chronic nephropathy in human recipients of cardiac allografts","volume":"17","author":"Moran M.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198501033120112"},{"key":"e_1_2_1_57_1","first-page":"305","article-title":"Cyclosporin Ainduced increases in renin storage and release","volume":"37","author":"Baxter C.R.","year":"1982","journal-title":"Res. Comm. Chem. Pathol. Pharmacol."},{"key":"e_1_2_1_58_1","unstructured":"Tegzess C.:Effect of CsA on renal blood flow. Actua Sandoz (in press)."},{"key":"e_1_2_1_59_1","first-page":"155","article-title":"Renal dysfunction in animal models of cyclosporine toxicity","volume":"17","author":"Paller M.S.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_60_1","first-page":"145","article-title":"Cyclosporine nephrotoxicity: Studies in laboratory animals","volume":"17","author":"Sullivan B.A.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2409598"},{"key":"e_1_2_1_62_1","first-page":"2782","article-title":"Glomerular thrombi and infarction in rabbits with serum sickness following cyclosporine therapy","volume":"15","author":"Neild G.H.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_63_1","first-page":"5","article-title":"Cyclosporine: The agent and its actions","volume":"17","author":"Kahan B.D.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112033052306"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90842-0"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91610-1"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197911000-00021"},{"key":"e_1_2_1_68_1","first-page":"2787","article-title":"Occurrence of haemolytic uraemic syndrome under cyclosporine treatment: Accident or possible side effect mediated by a lack of prostacyclin\u2010stimulating plasma factor?","volume":"15","author":"Leithner S.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)92829-7"},{"key":"e_1_2_1_70_1","first-page":"159","article-title":"Human renal transplants. II. Immunofluorescent and immunoferritin studies","volume":"18","author":"Porter K.A.","year":"1968","journal-title":"Lab. Invest."},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.126.3.1059"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.3.962"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.3.623.623"},{"key":"e_1_2_1_74_1","unstructured":"Carlsen E. Courillon M.A. Prydz H.:Effect of cyclosporine A on procoagulant activity in mononuclear blood cells and monocytes in vitro. Clin. Exp. Immunol. (in press)."},{"key":"e_1_2_1_75_1","first-page":"2862","article-title":"The consequences of conversion from cyclosporine to azathioprine and prednisolone in renal allograft recipients","volume":"15","author":"Wood R.F.M.","year":"1983","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_76_1","first-page":"254","article-title":"Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine","volume":"17","author":"Chapman J.R.","year":"1985","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_77_1","unstructured":"Kahan B.D.:Overview: Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation (in press)."},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198412000-00022"}],"container-title":["World Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01655294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF01655294\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF01655294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01655294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:34:24Z","timestamp":1704994464000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/BF01655294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,6]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,6]]}},"alternative-id":["10.1007\/BF01655294"],"URL":"https:\/\/doi.org\/10.1007\/bf01655294","archive":["Portico"],"relation":{},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,6]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}